R. Andrew Eckert Net Worth

The estimated Net Worth of R Andrew Eckert is at least $1.82 Million dollars as of 22 May 2020. Mr. Eckert owns over 1,225 units of Varian Medical Systems stock worth over $236,004 and over the last 20 years he sold VAR stock worth over $1,214,341. In addition, he makes $371,996 as Independent Chairman of the Board at Varian Medical Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Eckert VAR stock SEC Form 4 insiders trading

R has made over 21 trades of the Varian Medical Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,225 units of VAR stock worth $20,255 on 22 May 2020.

The largest trade he's ever made was exercising 8,000 units of Varian Medical Systems stock on 6 May 2011 worth over $397,920. On average, R trades about 1,048 units every 49 days since 2004. As of 22 May 2020 he still owns at least 14,273 units of Varian Medical Systems stock.

You can see the complete history of Mr. Eckert stock trades at the bottom of the page.

R. Andrew Eckert biography

R. Andrew Eckert serves as Independent Chairman of the Board of the Company. Chief Executive Officer, Acelity L.P., Inc., a global advanced wound care company (April 2017—October 2019) • ?Chief Executive Officer, Valence Health, a healthcare solutions company (August 2015—October 2016) • ?Chief Executive Officer, TriZetto Corporation, a healthcare IT solutions firm (March 2014—November 2014) • ?Chief Executive Officer, CRC Health Corporation, a provider of substance abuse treatment and adolescent youth services (January 2011—March 2014) • ?Managing Director, Symphony Technology Group, a private equity firm (October 2009—January 2011) • ?President and Chief Executive Officer, Eclipsys Corporation, a former publicly traded healthcare information management software provider (October 2005—May 2009) • ?Chief Executive Officer, SumTotal Systems, Inc., an enterprise software provider (2004—2005) • ?Chief Executive Officer, Docent Inc., an enterprise software provider that was acquired by SumTotal Systems (2002—2004) • ?Chairman and Chief Executive Officer, ADAC Laboratories, a former publicly traded medical imaging company (1997—2001) • ?Other Current Public Company Board Memberships: Becton, Dickinson and Company, a global medical technology company.

What is the salary of R Eckert?

As the Independent Chairman of the Board of Varian Medical Systems, the total compensation of R Eckert at Varian Medical Systems is $371,996. There are 3 executives at Varian Medical Systems getting paid more, with Dow Wilson having the highest compensation of $9,446,300.

How old is R Eckert?

R Eckert is 58, he's been the Independent Chairman of the Board of Varian Medical Systems since 2014. There are 6 older and 7 younger executives at Varian Medical Systems. The oldest executive at Varian Medical Systems, Inc. is David Illingworth, 66, who is the Independent Director.

What's R Eckert's mailing address?

R's mailing address filed with the SEC is C/O BECTON, DICKINSON AND COMPANY, , FRANKLIN LAKES, NJ, 07417.

Insiders trading at Varian Medical Systems

Over the last 21 years, insiders at Varian Medical Systems have traded over $57,574,967 worth of Varian Medical Systems stock and bought 500 units worth $22,595 . The most active insiders traders include Kent J Thiry, Timothy E Guertin, and Dow R Wilson. On average, Varian Medical Systems executives and independent directors trade stock every 11 days with the average trade being worth of $181,124. The most recent stock trade was executed by Jesse Michael Bruff on 1 March 2021, trading 6,499 units of VAR stock currently worth $1,142,589.

What does Varian Medical Systems do?

Complete history of Mr. Eckert stock trades at Becton Dickinson & Co and Varian Medical Systems

Varian Medical Systems executives and stock owners

Varian Medical Systems executives and other stock owners filed with the SEC include:

• Dow Wilson,
  Chief Executive Officer, Director
• Kolleen Kennedy,
  President - Proton Solutions Division and Chief Growth Officer
• Chris Toth,
  President, Chief Operating Officer
• R. Andrew Eckert,
  Independent Chairman of the Board
• Jeffrey Balser,
  Independent Director
• Judy Bruner,
  Independent Director
• Anat Ashkenazi,
  Independent Director
• Jean-Luc Butel,
  Independent Director
• Regina Dugan,
  Independent Director
• David Illingworth,
  Independent Director
• Phillip Febbo,
  Independent Director
• Michael Hutchinson,
  Senior Vice President, Chief Legal Officer
• Francis Facchini,
  President, Interventional Solutions Business
• Anshul Maheshwari,
  Vice President, Treasurer and Investor Relations
• Michelle Le Beau,
  Independent Director
• J. Michael Bruff,
  Chief Financial Officer, Senior Vice President - Finance
• Magnus Momsen,
  SVP, CAO, Corporate Controller
• Mark R Laret,
  Director
• Jose Baselga,
  Director
• John W Kuo,
  SVP, Gen Counsel and Secretary
• Gary E Jr Bischoping,
  SVP, Finance & CFO
• Susan L Bostrom,
  Director
• Timothy E Guertin,
  Director
• Clarence R Verhoef,
  SVP, Finance, Corp Controller
• Venkatraman Thyagarajan,
  Director
• Sunny Sanyal,
  SVP and President, ICB
• Robert H Kluge,
  Corporate Vice President
• Richard M Levy,
  President and CEO
• Ruediger Naumann Etienne,
  Director
• John Seely Brown,
  Director
• Erich R Reinhardt,
  Director
• Tai Yun Chen,
  VP and Corporate Controller
• David W Jr Martin,
  Director
• Steven A Leibel,
  Director
• Kent J Thiry,
  Director
• Allen S Lichter,
  Director
• Samuel Hellman,
  Director
• Crisanto C Raimundo,
  Corporate Controller
• Terry R Lautenbach,
  Director
• Joseph B Phair,
  VP Admin,Gen Counsel,Secretary
• Elisha W Finney,
  Corporate Vice President & CFO
• Kevin O'reilly,
  SVP, President of Oncology Sys